España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Opthea
OPT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$5.56
0.07
1.28%
At close: -
$5.10
-0.46
-8.27%
After Hours: Jan 31, 4:14 AM EDT
Get Report
Comment
Opthea (OPT) Forecast
News
Earnings
Opthea (OPT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Opthea (NASDAQ:OPT) Stock
Opthea Stock (NASDAQ: OPT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 30, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, January 29, 2025
HC Wainwright & Co. Reiterates Buy on Opthea,...
Benzinga Newsdesk
Tuesday, January 07, 2025
Opthea Limited shares are trading higher afte...
Benzinga Newsdesk
Opthea Announced The Publication Of Its Phase...
Benzinga Newsdesk
Tuesday, October 08, 2024
Opthea Appoints Parisa Zamiri And Tom Reilly ...
Benzinga Newsdesk
Tuesday, October 01, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Thursday, September 19, 2024
Darden Restaurants Posts Q1 Results, Joins Tesla, Nvidia, XPeng And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Wednesday, September 18, 2024
Opthea Announced The Completion Of Its Drug S...
Benzinga Newsdesk
Thursday, September 05, 2024
Opthea Taps Daniel Geffken Of Danforth Advis...
Benzinga Newsdesk
Tuesday, September 03, 2024
HC Wainwright & Co. Maintains Buy on Opthea, ...
Benzinga Newsdesk
Friday, August 30, 2024
Opthea FY Adjusted EPS $(0.27) Up From $(0.30...
Benzinga Newsdesk
Monday, July 15, 2024
Reported Sunday, Opthea Successfully Complete...
Benzinga Newsdesk
Friday, June 14, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Trading Halt: Halt status updated at 7:00:00 ...
Benzinga Newsdesk
Wednesday, June 12, 2024
Reported Earlier, Opthea Secures Funding Path...
Benzinga Newsdesk
Thursday, June 06, 2024
Trading Halt: Halted at 7:10:48 p.m. ET - Tra...
Benzinga Newsdesk
Tuesday, May 28, 2024
Opthea's Pivotal Phase 3 Trials For Soziniber...
Benzinga Newsdesk
Thursday, May 09, 2024
Watching Protara Therapeutics, Opthea Ltd.; S...
Benzinga Newsdesk
Wednesday, February 28, 2024
Opthea Reports $157.1M In Cash And Cash Equiv...
Benzinga Newsdesk
Wednesday, February 14, 2024
Opthea Has Completed Enrollment In COAST Phas...
Benzinga Newsdesk
Wednesday, January 24, 2024
Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, December 27, 2023
Why Is Retinal Diseases-Focused Opthea Stock Trading Higher Today?
Vandana Singh
Opthea shares are trading higher after the co...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Opthea Expects To Receive The Remaining $35M ...
Benzinga Newsdesk
Tuesday, December 19, 2023
Opthea Has Received An A$8.8M ($5.9M) R&D Tax...
Benzinga Newsdesk
Friday, October 27, 2023
Opthea Limited Appoints Frederic Guerard As C...
Benzinga Newsdesk
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, September 13, 2023
Oppenheimer Maintains Outperform on Opthea, L...
Benzinga Newsdesk
Friday, September 08, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, August 28, 2023
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Opthea Successfully Completes Institutional O...
Benzinga Newsdesk
Tuesday, August 01, 2023
HC Wainwright & Co. Reiterates Buy on Opthea,...
Benzinga Newsdesk
Wednesday, July 26, 2023
American Medical Association's United States ...
Benzinga Newsdesk
Tuesday, May 16, 2023
EF Hutton Reiterates Buy on Opthea, Maintains...
Benzinga Newsdesk
Monday, April 17, 2023
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023
Benzinga Insights
Opthea shares are trading higher after EF Hut...
Michael Horton
EF Hutton Initiates Coverage On Opthea with B...
Benzinga Newsdesk
Friday, March 31, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Why Chicken Soup for the Soul Entertainment Shares Are Trading Lower By 30%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Monday, March 13, 2023
Oppenheimer Maintains Outperform on Opthea, L...
Benzinga Newsdesk
Wednesday, March 08, 2023
Earnings Scheduled For March 8, 2023
Benzinga Insights
Tuesday, March 07, 2023
Opthea Receives $6.3M Research And Developmen...
Benzinga Newsdesk
Friday, February 24, 2023
HC Wainwright & Co. Reiterates Buy on Opthea,...
Benzinga Newsdesk
Monday, February 13, 2023
Opthea's Phase 2B Results Of OPT-302, Anti-VE...
Benzinga Newsdesk
Friday, February 03, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Wednesday, February 01, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Thursday, December 08, 2022
HC Wainwright & Co. Initiates Coverage On Opt...
Benzinga Newsdesk
Tuesday, November 08, 2022
Earnings Scheduled For November 8, 2022
Benzinga Insights
Show More
